There's nothing like a tie-up with a major name in an industry to juice the value of a stock.
The investment bank analysts who follow these stocks think they could deliver enormous gains in the not-so-distant future.
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 20% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...
Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities violations and breach of fiduciary duty claims...
The Medicare Advantage insurer reported a loss in its fourth-quarter earnings.
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of -3.33% and 6.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NovoCure (NVCR) delivered earnings and revenue surprises of -12.50% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Brightside Health, a telehealth platform that delivers life-changing mental health care to individuals with mild-to-severe clinical depression, anxiety, and other mood disorders, announced today the appointment...
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 12% and 8%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?